NERV compared with LGVN: revenue, margins and what each company keeps, and the suppliers and customers both name

NERVMinerva Neurosciences, Inc.

Mkt capRevenueRevenue

LGVNLongeveron Inc.

Mkt capRevenueRevenue

Compare

NERVMinerva Neurosciences, Inc.

LGVNLongeveron Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Supply-chain overlap

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only NERV 7

RPRXRoyalty Pharma plc ("Royalty Pharma")customer

—Catalentunlistedsupplier

—Catalent Germany Schorndorf GmbHunlistedsupplier

—Dr. Inderjit Kaulunlistedsupplier

3 more · NERV chain ›

Shared 0

No shared counterparties.

Only LGVN 1

—The University of Miamiunlistedsupplier

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

NERVMinerva Neurosciences, Inc.

2.30▲+2.73%· post 2.30

Mkt cap$110.8MRevenue—Revenue—

LGVNLongeveron Inc.

1.78▲+1.71%· post 1.78

ClosedOct 30 '26

Mkt cap$5.2MRevenue$287,000Q2 FY26Revenue$1MFY25

Compare

ClosedOct 30 '26

NERVMinerva Neurosciences, Inc.

LGVNLongeveron Inc.

2.30▲+2.73%post 2.30

Price

1.78▲+1.71%post 1.78

$110.8M

Mkt cap

$5.2M

—

Revenue

$287,000Q2 FY26

—

Revenue

$1MFY25

NERV2.30▲+2.73%vsLGVN1.78▲+1.71%ClosedOct 30 '26